Hanger Orthopedic Group, Inc. Receives Upgrade From Moody's Investors Service
BETHESDA, Md., July 31 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR ) is pleased to announce that Moody's Investors Service raised its rating on Hanger Orthopedic Group, Inc. to "B1" from "B2." Moody's also raised the issue level rating on Hanger's senior secured debt...Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress
NEW YORK, July 14 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) today announced that it will release financial results for the second quarter ended June 30, 2009 on Monday, July 27, 2009 after the market close. In addition, Eamonn Hobbs, the Company's new Preside...American Investors Highlight Successes in Eastern Germany
CHICAGO, June 12 /PRNewswire/ -- Germany remains an attractive investment location for North American companies, driven by the eastern federal states. This is in large part due to the robust high-tech industries and continuing growth potential despite the economic crisis. American investor int...A Message to Investors from China Sky One Medical, Inc.
HARBIN, China, April 21 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today responded to comm...Varian Medical Systems Schedules Mid-Year Review With Investors in Boston
PALO ALTO, Calif., April 2 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR ) announced today that its management will hold a mid-year review for investors from noon through 2 p.m. on May 7, 2009 in Boston at the Hyatt Regency hotel located at 1 Avenue De Lafayette. Management pres...Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Cowen Conference
ROCKVILLE, Md., March 13 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) announced today that its presentation at the Cowen and Company 29th Annual Health Care Conference will be webcast and may be accessed at www.hgsi.com . (Logo: http://www.newscom.com/cgi-bin/prnh...CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
New equity infusion continues funding CoAxia's studies of its NeuroFlo(TM) Perfusion Augmentation Therapy for Ischemic Stroke MINNEAPOLIS, April 1, 2008 /PRNewswire/ -- CoAxia(TM), Inc. of Maple Grove, MN, today announced the closing of an additional $11.5M financing from current inve...Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Accelrys, Inc. (NASDAQ:ACCL), the leading provider of scientific business intelligence software and services, announced today that its CFO, Rick Russo, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York on July 1...Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
...d similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict a...Labopharm files New Drug Submission with Health Canada for novel antidepressant
...s countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forw...Cyberonics Provides Update on Depression Post-Approval Study
.... We are not assuming any duty to update this information should those facts change or should we no longer believe the assumptions to be reasonable. investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning completing follow-up on pa...NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
...taining regulatory approval for NeurogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. NeurogesX, Inc. The Ruth Group St...BIO-key to Respond in Court to a Lawsuit Filed by Two Investors
WALL, N.J., March 4 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, today announced that on or before March 16, 2009 it will file, in the United States District Court for the S...Aware, Inc. Reports Second Quarter 2009 Financial Results
...expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be ...Aware, Inc. Announces Q2'09 Earnings Conference Call
...also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents ( www.streetevents.com ), a ...Stanford researchers publish comprehensive model for medical device development
...d way. "Clearly there are benefits associated with having a rigorous process and clearly defined procedures for all stakeholders in the processfrom investors and engineers to researchers and regulators," says coauthor John Linehan, Ph.D., professor of medicine and biomedical engineering and director of the ...Novel handheld device detects anthrax with outstanding accuracy and reliability
...otential markets for Veritide in North America and around the globe. We currently are in the process of identifying potential partners and additional investors to ensure this important technology is available worldwide." ...Promising device snags young inventors coveted spot at IShow
...pital Research Institute, said the device has received good reviews from patients involved in preliminary clinical testing, which will make convincing investors that much easier. "I am excited about the marketing presentation, even with limited experience with investors, because I look forward to telling ou...Aware, Inc. Reports First Quarter 2009 Financial Results
...expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be ...Aware, Inc. Reports First Quarter 2009 Financial Results
...expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be ...Aware, Inc. Announces Q1 '09 Earnings Conference Call
...also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents ( www.streetevents.com ), a ...KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd
SpringTree Special Opportunities Fund, LP ("SpringTree") announced today its AU$25,500,000 investment in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA Capital acted as the exclusive financial advisor to SpringTree's general part...Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference
ROCKVILLE, Md., March 27 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) announced today that its presentation at the 4th Annual Citi Biotech Day will be webcast and may be accessed at www.hgsi.com . (Logo: http://www.newscom.com/cgi-bin/prnh/200...Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
ROCKVILLE, Md., Jan. 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) announced today that its presentation at the 27th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HG...Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
CINCINNATI, Dec. 9 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ) a leading, global full-service clinical research organization, today announced President Simon Higginbotham will participate in the annual Raymond James Boston Fall Investors Conference. The conference will be held at The State ...